Ground Swell Capital’s Kite Pharma, Inc. KITE Stock Holding History

Ground Swell Capital’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$24K	Buy	+842	New	+$20.8K	0.05%	460

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Ground Swell Capital's KITE Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Kite Pharma, Inc. (KITE) in Q3 2014: 842 shares worth $24K. The stake represents 0.05% of the portfolio and ranks #460 among its holdings.

62 funds tracked by Wall St. Rank hold KITE as of Q3 2014.

Ground Swell Capital held 842 shares of Kite Pharma, Inc. worth $24K as of Q3 2014.
Kite Pharma, Inc. was a new Ground Swell Capital position in Q3 2014.
Kite Pharma, Inc. made up 0.05% of Ground Swell Capital's portfolio in Q3 2014, its #460 holding.
62 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.